<DOC>
	<DOCNO>NCT00317174</DOCNO>
	<brief_summary>The purpose study follow : - To evaluate persistence antibody presence immune memory induce 3-dose primary vaccination Tritanrix™-HepB/Hib-MenAC ( three formulation ) study DTPwHB/HibMenACTT001 ( CPMS No . 759346/001 ) give unconjugated PRP , PSA PSC 10 month age one subset subject . - To evaluate persistence antibody pertain primary vaccination booster response Tritanrix™-HepB/Hib2.5 vaccine Tritanrix™-HepB/Hib-MenAC vaccine 15-18 month age subset subject .</brief_summary>
	<brief_title>A Study Assess Antibody Persistence , Boostability &amp; Safety Previously Primed Subjects .</brief_title>
	<detailed_description>This study conduct two stage : At 10 month age , half subject receive dose plain meningococcal AC PRP polysaccharide ( PS ) vaccine 10 month age . At 15 18 month age ( DTP booster phase ) , subject receive booster dose Tritanrix™-HepB/Hib-MenAC Tritanrix™-HepB/Hib2.5 .</detailed_description>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>Inclusion criterion : • Healthy child 10 month participate study DTPwHB/HibMenACTT001 ( CPMS No . 759346/001 ) , write informed consent obtain parent . Exclusion criterion : Planned administration/ administration vaccine foreseen study protocol period start 30 day end 30 day administration study vaccine exception oral polio vaccine ( OPV ) . Use investigational nonregistered product ( drug vaccine ) study vaccine within 30 day precede first dose study vaccine , plan use study period . Chronic administration ( &gt; 14 day ) immunosuppressant immunemodifying drug within 6 month prior first vaccine dose . Previous booster vaccination diphtheria , tetanus , pertussis , hepatitis B , serogroups A C meningococcal disease and/or Hib since last visit study 759346/001 . History of/known exposure diphtheria , tetanus , pertussis , hepatitis B , serogroups A C meningococcal and/or Hib disease . Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection .</criteria>
	<gender>All</gender>
	<minimum_age>10 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>